ADDN is actively looking for new opportunities with commercial and academic groups for co-developing potential drugs and/or fee-for-service projects.
Fields of interest include infectious diseases, cancer, inflammation and CNS diseases.
Expertise is available for all steps in the preclinical drug discovery process from drug discovery to evaluation. The state-of-the-art laboratories use an electronic notebook system to record and facilitate research progress.
If you wish to collaborate with ADDN please contact Dr. Jurgen Joossens.